Here are five key notes:
1. In June 2015, Episurf Medical received the ISO 13485:2012 and Annex II certification which allows the company to award the CE mark to its own products.
2. The newly certified product is Episurf Medical’s Episealer Femoral Twin.
3. The Episealer Femoral Twin is a patient-specific implant for the treatment of larger and more elongated cartilage and underlying bone defects in the condyle and trochlea area.
4. The product has received eight pre-orders.
5. Episurf Medical focuses on providing minimally invasive and personalized treatment alternatives to patients with musculoskeletal conditions.
More articles on devices:
Amendia, InVivo Therapeutics, Medtronic & more — 14 key notes
Massachusetts Biotechnology Council names InVivo Therapeutics an industry innovator: 5 notes
Bone Solutions of Dallas receives FDA approval for Activated Spinal Fusion Slurry — 4 facts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
